明德生物(002932.SZ):全资子公司通过高新技术企业认定并取得证书
格隆汇2月8日丨明德生物(002932.SZ)宣布,公司全资子公司武汉明志在2020年通过高新技术企业的认定,并于近日收到由湖北省科学技术厅、湖北省财政厅、国家税务总局湖北省税务局联合颁发的《高新技术企业证书》,证书编号:GR202042001902,发证时间:2020年12月1日,有效期:三年。
根据《高新技术企业认定管理办法》及《中华人民共和国企业所得税法》等相关规定,武汉明志通过高新技术企业认定当年起三年内可享受国家关于高新技术企业的相关优惠政策,按15%的税率缴纳企业所得税。
武汉明志该次获得高新技术企业证书不会对公司2020年度的经营业绩产生重大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.